Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / J•• W•••••••• S•••••••

A•••••••• C•••••• P••••••• to Sell J•• W•••••••• S••••••• to C•••

Exit to a strategic buyerannouncedannounced Feb 5, 2024Fact
What happened
Target
J•• W•••••••• S•••••••
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
healthcare / clinic, hospital
Target location
unknown
Seller kind
Sponsor
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
8 named
Buy side
  • C••• G•••• I•••Strategic acquirerconfirmed
    “A•••••••• C•••••• P••••••• (“A••••••••”), a Washington, D.C.-area private investment firm specializing in government regulated industries, today announced it has agreed to sell J•• W•••••••• S••••••• (“J&J” or the “Company”) to C••• G•••• I••• (NYSE: C•••).”
  • G••••• A••••••Deal partnerconfirmed
    “G••••• A••••••, a Principal at A•••••••• C•••••• P••••••• added: “J&J continues to prove itself as a highly durable industry leader, and its unparalleled commitment to its customers’ success has led to superior performance in support of U.S. Federal Government infrastructure.”
  • M•••••• H••••• L••••••••Deal partnerconfirmed
    “M•••••• L••••••••, a Managing Partner at A••••••••, said, “During our partnership, J&J has achieved significant organic growth by winning large, transformational and critical contracts at facilities where failure is simply not an option for the United States.”
Sell side
  • A•••••••• C•••••• P•••••••Sellerconfirmed
    “Achieving significant organic growth during its four-year partnership with A••••••••, J&J is well-positioned under C•••’s stewardship to continue its growth trajectory | published on A•••••••• C•••••• P•••••••'s own news page arlingtoncap.com”
Advisory side
  • J••• M••••• S••••••••• L••Financial adviserconfirmed
    “J••• M••••• S••••••••• L•• is serving as financial advisor to J&J and Sheppard Mullin Richter & Hampton LLP is serving as legal advisor to J&J and A•••••••• C•••••• P•••••••.”
  • C•••Financial adviserconfirmed
    “C••• is serving as financial advisor to C••• and Simpson Thacher & Bartlett LLP and ArentFox Schiff LLP are serving as legal advisors.”
Side not stated
  • S•••• K•••••Managementconfirmed
    “Our partnership with A•••••••• allowed us to stay true to these core values while accelerating organic growth in all parts of our business,” commented S•••• K•••••, CEO of J&J. “Over the last four years and with excellent guidance from A••••••••, we have been able to make great strides in further re”
  • J•• W•••••••• S•••••••Targetconfirmed
    “A•••••••• C•••••• P••••••• (“A••••••••”), a Washington, D.C.-area private investment firm specializing in government regulated industries, today announced it has agreed to sell J•• W•••••••• S••••••• (“J&J” or the “Company”) to C••• G•••• I••• (NYSE: C•••).”
Evidence
“A•••••••• C•••••• P••••••• (“A••••••••”), a Washington, D.C.-area private investment firm specializing in government regulated industries, today announced it has agreed to sell J•• W•••••••• S••••••• (“J&J” or the “Company”) to C••• G•••• I••• (NYSE: C•••).”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026
A•••••••• C•••••• P••••••• to Sell J•• W•••••••• S••••••• to C••• | Private Equity Intelligence | DFX